Ferenc Martényi

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Sandeep T. Patil, Lu Zhang, Ferenc Martényi et al. · Nature Medicine · 2007 · 1K citations

Medicine, Pharmacology, Psychiatry +12

Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor

Patrick C. May, Robert A. Dean, Stephen L. Lowe et al. · Journal of Neuroscience · 2011 · 369 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

Matthew Davis, Scott W. Johnson, Stephanie Cline et al. · Current Alzheimer Research · 2018 · 232 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Fluoxetine Versus Placebo in Posttraumatic Stress Disorder

Ferenc Martényi, Eileen B. Brown, Harry Zhang et al. · The Journal of Clinical Psychiatry · 2002 · 216 citations

Medicine, Pharmacotherapy, Psychiatry +13

The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans

Patrick C. May, Brian A. Willis, Stephen L. Lowe et al. · Journal of Neuroscience · 2015 · 205 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17